Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q41423065
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010835.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q41423065
|
024
|
|
|
‡a
0000-0001-9577-3839
‡2
orcid
|
024
|
|
|
‡a
14036765400
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q41423065
|
100
|
0 |
|
‡a
Carme Costa
‡9
sl
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Carme Costa
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Carme Costa
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Carme Costa
‡c
investigadora
‡9
es
|
400
|
0 |
|
‡a
Carme Costa
‡c
investigadora
‡9
ast
|
670
|
|
|
‡a
Author's Adult onset leukodystrophy with neuroaxonal spheroids and demyelinating plaque-like lesions
|
670
|
|
|
‡a
Author's Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases
|
670
|
|
|
‡a
Author's Assessment of calcium-binding proteins
|
670
|
|
|
‡a
Author's Assessment of calcium-binding proteins (Parvalbumin and Calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains.
|
670
|
|
|
‡a
Author's Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
|
670
|
|
|
‡a
Author's Central nervous system extracellular matrix changes in a transgenic mouse model of bovine spongiform encephalopathy
|
670
|
|
|
‡a
Author's Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy
|
670
|
|
|
‡a
Author's Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
|
670
|
|
|
‡a
Author's Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.
|
670
|
|
|
‡a
Author's Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design
|
670
|
|
|
‡a
Author's Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
|
670
|
|
|
‡a
Author's Hsp70 regulates immune response in experimental autoimmune encephalomyelitis
|
670
|
|
|
‡a
Author's Hypomyelination in three Weimaraner dogs
|
670
|
|
|
‡a
Author's Immunohistochemical approach to the pathogenesis of bovine spongiform encephalopathy in its early stages
|
670
|
|
|
‡a
Author's Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
|
670
|
|
|
‡a
Author's Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis
|
670
|
|
|
‡a
Author's Lack of PrP
|
670
|
|
|
‡a
Author's Lack of PrP(sc) immunostaining in intracranial ectopic lymphoid follicles in a sheep with concomitant non-suppurative encephalitis and Nor98-like atypical scrapie: a case report
|
670
|
|
|
‡a
Author's Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.
|
670
|
|
|
‡a
Author's Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse.
|
670
|
|
|
‡a
Author's Molecular profiling and comparison of field transmissible spongiform encephalopathy cases diagnosed in Catalunya
|
670
|
|
|
‡a
Author's Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
|
670
|
|
|
‡a
Author's Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis
|
670
|
|
|
‡a
Author's Respuesta
|
670
|
|
|
‡a
Author's Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis
|
670
|
|
|
‡a
Author's Stem cell-based treatment of neurologic diseases
|
670
|
|
|
‡a
Author's Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy
|
670
|
|
|
‡a
Author's Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
|
670
|
|
|
‡a
Author's Value of NMO-IgG determination at the time of presentation as CIS
|
909
|
|
|
‡a
(scopus) 14036765400
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000195773839
‡9
1
|
919
|
|
|
‡a
differentialexpressionofsema3aandsema7ainamurinemodelofmultiplesclerosisimplicationsforatherapeuticdesign
‡A
Differential expression of sema3A and sema7A in a murine model of multiple sclerosis: Implications for a therapeutic design
‡9
1
|
919
|
|
|
‡a
clinicalandhistopathologicalameliorationofexperimentalautoimmuneencephalomyelitisbyaavvectorsexpressingasolubleinterleukin23receptor
‡A
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.
‡9
1
|
919
|
|
|
‡a
assessmentofcalciumbindingproteinsparvalbuminandcalbindin50028kandperineuronalnetsinnormalandscrapieaffectedadultsheepbrains
‡A
Assessment of calcium-binding proteins (Parvalbumin and Calbindin D-28K) and perineuronal nets in normal and scrapie-affected adult sheep brains.
‡9
1
|
919
|
|
|
‡a
assessmentofcalciumbindingproteins
‡A
Assessment of calcium-binding proteins
‡9
1
|
919
|
|
|
‡a
aquaporin1andaquaporin4overexpressioninbovinespongiformencephalopathyinatransgenicmurinemodelandincattlefieldcases
‡A
Aquaporin 1 and aquaporin 4 overexpression in bovine spongiform encephalopathy in a transgenic murine model and in cattle field cases
‡9
1
|
919
|
|
|
‡a
adultonsetleukodystrophywithneuroaxonalspheroidsanddemyelinatingplaquelikelesions
‡A
Adult onset leukodystrophy with neuroaxonal spheroids and demyelinating plaque-like lesions
‡9
1
|
919
|
|
|
‡a
breastregressionprotein39isnotrequiredforexperimentalautoimmuneencephalomyelitisinduction
‡A
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
‡9
1
|
919
|
|
|
‡a
valueofnmoiggdeterminationatthetimeofpresentationascis
‡A
Value of NMO-IgG determination at the time of presentation as CIS
‡9
1
|
919
|
|
|
‡a
chitinase3like1prognosticbiomarkerinclinicallyisolatedsyndromes
‡A
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
‡9
1
|
919
|
|
|
‡a
treatmentwithmogdnavaccinesinducescd4+cd25+foxp3+regulatorytcellsandupregulatesgeneswithneuroprotectivefunctionsinexperimentalautoimmuneencephalomyelitis
‡A
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
‡9
1
|
919
|
|
|
‡a
stressresponseinthecentralnervoussystemofatransgenicmousemodelofbovinespongiformencephalopathy
‡A
Stress response in the central nervous system of a transgenic mouse model of bovine spongiform encephalopathy
‡9
1
|
919
|
|
|
‡a
stemcellbasedtreatmentofneurologicdiseases
‡A
Stem cell-based treatment of neurologic diseases
‡9
1
|
919
|
|
|
‡a
semaphorin7aasapotentialtherapeutictargetformultiplesclerosis
‡A
Semaphorin 7A as a Potential Therapeutic Target for Multiple Sclerosis
‡9
1
|
919
|
|
|
‡a
respuesta
‡A
Respuesta
‡9
1
|
919
|
|
|
‡a
myeloidderivedsuppressorcellsexpressingaselfantigenameliorateexperimentalautoimmuneencephalomyelitis
‡A
Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis
‡9
1
|
919
|
|
|
‡a
multicentrecomparisonofadiagnosticassayaquaporin4antibodiesinneuromyelitisoptica
‡A
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
‡9
1
|
919
|
|
|
‡a
molecularprofilingandcomparisonoffieldtransmissiblespongiformencephalopathycasesdiagnosedincatalunya
‡A
Molecular profiling and comparison of field transmissible spongiform encephalopathy cases diagnosed in Catalunya
‡9
1
|
919
|
|
|
‡a
mappingofaggrecanhyaluronicacidheparansulphateproteoglycansandaquaporin4inthecentralnervoussystemofthemouse
‡A
Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans and aquaporin 4 in the central nervous system of the mouse.
‡9
1
|
919
|
|
|
‡a
longtermrestorationofthymidinephosphorylasefunctionandnucleosidehomeostasisusinghematopoieticgenetherapyinamurinemodelofmitochondrialneurogastrointestinalencephalomyopathy
‡A
Long-Term Restoration of Thymidine Phosphorylase Function and Nucleoside Homeostasis Using Hematopoietic Gene Therapy in a Murine Model of Mitochondrial Neurogastrointestinal Encephalomyopathy.
‡9
1
|
919
|
|
|
‡a
lackofprpscimmunostaininginintracranialectopiclymphoidfolliclesinasheepwithconcomitantnonsuppurativeencephalitisandnor98likeatypicalscrapieacasereport
‡A
Lack of PrP(sc) immunostaining in intracranial ectopic lymphoid follicles in a sheep with concomitant non-suppurative encephalitis and Nor98-like atypical scrapie: a case report
‡9
1
|
919
|
|
|
‡a
lackofprp
‡A
Lack of PrP
‡9
1
|
919
|
|
|
‡a
inhibitionofdeltalikeligand4decreasesth1th17responseinamousemodelofmultiplesclerosis
‡A
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis
‡9
1
|
919
|
|
|
‡a
implicationofthetolllikereceptor4pathwayintheresponsetointerferonβinmultiplesclerosis
‡A
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
‡9
1
|
919
|
|
|
‡a
centralnervoussystemgeneexpressionchangesinatransgenicmousemodelforbovinespongiformencephalopathy
‡A
Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy
‡9
1
|
919
|
|
|
‡a
immunohistochemicalapproachtothepathogenesisofbovinespongiformencephalopathyinitsearlystages
‡A
Immunohistochemical approach to the pathogenesis of bovine spongiform encephalopathy in its early stages
‡9
1
|
919
|
|
|
‡a
hypomyelinationin3weimaranerdogs
‡A
Hypomyelination in three Weimaraner dogs
‡9
1
|
919
|
|
|
‡a
hsp70regulatesimmuneresponseinexperimentalautoimmuneencephalomyelitis
‡A
Hsp70 regulates immune response in experimental autoimmune encephalomyelitis
‡9
1
|
919
|
|
|
‡a
centralnervoussystemextracellularmatrixchangesinatransgenicmousemodelofbovinespongiformencephalopathy
‡A
Central nervous system extracellular matrix changes in a transgenic mouse model of bovine spongiform encephalopathy
‡9
1
|
919
|
|
|
‡a
expressionofsemaphorin3asemaphorin7aandtheirreceptorsinmultiplesclerosislesions
‡A
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
PTBNP|1406005
|
996
|
|
|
‡2
BNC|981058525441406706
|
996
|
|
|
‡2
BLBNB|000167347
|
996
|
|
|
‡2
PTBNP|1769479
|
996
|
|
|
‡2
ISNI|0000000067970766
|
996
|
|
|
‡2
BNC|981058518461406706
|
996
|
|
|
‡2
ISNI|0000000068815952
|
996
|
|
|
‡2
BNC|981058516532806706
|
996
|
|
|
‡2
DNB|130293709
|
996
|
|
|
‡2
SUDOC|166541052
|
996
|
|
|
‡2
LC|no2012152228
|
996
|
|
|
‡2
BLBNB|000167357
|
996
|
|
|
‡2
BLBNB|000167355
|
996
|
|
|
‡2
ISNI|0000000059335949
|
996
|
|
|
‡2
PLWABN|9810621032205606
|
996
|
|
|
‡2
ISNI|0000000434947825
|
996
|
|
|
‡2
BLBNB|000508605
|
996
|
|
|
‡2
LC|n 2020250210
|
996
|
|
|
‡2
LC|n 2015236341
|
996
|
|
|
‡2
ISNI|0000000027399569
|
996
|
|
|
‡2
PTBNP|536968
|
996
|
|
|
‡2
LC|n 2009007731
|
996
|
|
|
‡2
ISNI|000000007021905X
|
996
|
|
|
‡2
PTBNP|225669
|
996
|
|
|
‡2
LC|nb2004307244
|
996
|
|
|
‡2
PTBNP|1343950
|
996
|
|
|
‡2
BNE|XX1102713
|
996
|
|
|
‡2
PTBNP|187529
|
996
|
|
|
‡2
ISNI|0000000069700313
|
996
|
|
|
‡2
BNE|XX1649365
|
996
|
|
|
‡2
BNC|981060888501706706
|
996
|
|
|
‡2
PTBNP|234035
|
996
|
|
|
‡2
LIH|LNB:C_b__w__i_;=CP
|
996
|
|
|
‡2
ICCU|CUBV160671
|
996
|
|
|
‡2
ISNI|0000000067996819
|
996
|
|
|
‡2
BLBNB|000313406
|
996
|
|
|
‡2
BNE|XX1579861
|
996
|
|
|
‡2
ISNI|0000000067746561
|
996
|
|
|
‡2
ISNI|0000000059570949
|
996
|
|
|
‡2
ISNI|0000000111088106
|
996
|
|
|
‡2
LC|n 90670492
|
996
|
|
|
‡2
BNC|981058512378206706
|
996
|
|
|
‡2
BNC|981058554567006706
|
996
|
|
|
‡2
LC|no2019156185
|
996
|
|
|
‡2
BIBSYS|90344967
|
996
|
|
|
‡2
ISNI|0000000373445003
|
996
|
|
|
‡2
ISNI|0000000117811932
|
996
|
|
|
‡2
CAOONL|ncf10724190
|
996
|
|
|
‡2
SUDOC|183144260
|
996
|
|
|
‡2
PTBNP|1921074
|
996
|
|
|
‡2
ISNI|0000000069815508
|
996
|
|
|
‡2
BNC|981058509056606706
|
996
|
|
|
‡2
BNF|14038357
|
996
|
|
|
‡2
BNC|981058509169406706
|
996
|
|
|
‡2
BNE|XX4614962
|
996
|
|
|
‡2
PTBNP|199643
|
996
|
|
|
‡2
JPG|500223183
|
996
|
|
|
‡2
BNE|XX945546
|
996
|
|
|
‡2
LC|no 91019771
|
996
|
|
|
‡2
BNC|981058512017306706
|
996
|
|
|
‡2
DNB|1060925281
|
996
|
|
|
‡2
SUDOC|25473717X
|
996
|
|
|
‡2
DNB|1060669064
|
996
|
|
|
‡2
ISNI|000000006940133X
|
996
|
|
|
‡2
LC|nr 00001229
|
996
|
|
|
‡2
ISNI|0000000111104700
|
996
|
|
|
‡2
BIBSYS|90278985
|
996
|
|
|
‡2
BLBNB|000492755
|
996
|
|
|
‡2
PTBNP|1686015
|
996
|
|
|
‡2
DNB|1037761111
|
996
|
|
|
‡2
PTBNP|1366384
|
996
|
|
|
‡2
SUDOC|252982983
|
996
|
|
|
‡2
ISNI|0000000354411107
|
996
|
|
|
‡2
SUDOC|165872330
|
996
|
|
|
‡2
PTBNP|225032
|
996
|
|
|
‡2
PTBNP|1309487
|
996
|
|
|
‡2
PTBNP|51934
|
996
|
|
|
‡2
ISNI|0000000078035917
|
996
|
|
|
‡2
LC|nr2005021620
|
996
|
|
|
‡2
BLBNB|001440134
|
996
|
|
|
‡2
J9U|987007327943305171
|
996
|
|
|
‡2
BNE|XX5009129
|
996
|
|
|
‡2
PTBNP|119839
|
996
|
|
|
‡2
BIBSYS|90282904
|
996
|
|
|
‡2
PTBNP|196623
|
996
|
|
|
‡2
ISNI|0000000068794549
|
996
|
|
|
‡2
ISNI|0000000081658322
|
996
|
|
|
‡2
BNC|981058520408206706
|
996
|
|
|
‡2
ISNI|0000000029762544
|
996
|
|
|
‡2
NYNYRILM|940
|
996
|
|
|
‡2
BNF|16229154
|
996
|
|
|
‡2
ISNI|0000000450734301
|
996
|
|
|
‡2
PTBNP|1308826
|
996
|
|
|
‡2
BNE|XX4977668
|
996
|
|
|
‡2
LC|n 86129077
|
996
|
|
|
‡2
BNE|XX1548138
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|